Clinical trial
Postoperative Neurological Recovery and Risk Factor Analysis in Patients With Paralysis Due to Spinal Metastases
NCT07527728 is registered in ClinicalTrials.gov with Shanghai Changzheng Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Postoperative Neurological Recovery and Risk Factor Analysis in Patients With Paralysis Due to Spinal Metastases
- Lead sponsor
- Shanghai Changzheng Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 1, 2026
- Completion date
- June 30, 2028
- Enrollment
- 150 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic spinal tumors, neurological deficits, paralysis, spinal cord compression